(Q37759964)

22 August 2017

title

ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference (English)

1 reference

22 August 2017

A Shaw

23

0 references

Piotr Ponikowski

P Ponikowski

7

0 references

Claudio Ronco

C Ronco

28

0 references

Rinaldo Bellomo

6

R Bellomo

1 reference

22 August 2017

2

S D Anker

1 reference

22 August 2017

21

P McCullough

1 reference

Acute Dialysis Quality Initiative (ADQI) consensus group

22 August 2017

29

Acute Dialysis Quality Initiative (ADQI) consensus group

1 reference

22 August 2017

A Davenport

1

1 reference

22 August 2017

A Mebazaa

3

1 reference

22 August 2017

A Palazzuoli

4

1 reference

22 August 2017

G Vescovo

5

1 reference

22 August 2017

I Anand

8

1 reference

22 August 2017

N Aspromonte

9

1 reference

22 August 2017

S Bagshaw

10

1 reference

22 August 2017

T Berl

11

1 reference

22 August 2017

I Bobek

12

1 reference

22 August 2017

D N Cruz

13

1 reference

22 August 2017

L Daliento

14

1 reference

22 August 2017

M Haapio

15

1 reference

22 August 2017

H Hillege

16

1 reference

22 August 2017

A House

17

1 reference

22 August 2017

N Katz

18

1 reference

22 August 2017

A Maisel

19

1 reference

22 August 2017

S Mankad

20

1 reference

22 August 2017

F Ronco

22

1 reference

22 August 2017

G Sheinfeld

24

1 reference

22 August 2017

S Soni

25

1 reference

22 August 2017

N Zamperetti

26

1 reference

22 August 2017

P Zanco

27

1 reference

22 August 2017

language of work or name

English

0 references

publication date

20 May 2010

1 reference

Nephrology Dialysis Transplantation

22 August 2017

published in

1 reference

22 August 2017

volume

25

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

2077-2089

1 reference

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Epidemiology of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Renal artery stenosis: a common, treatable cause of renal failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Role of endogenous cardiotonic steroids in sodium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Anemia and heart failure in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Intradialytic complications during hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

[Neuromonitoring and neuroprotection in cardiac anaesthesia. Nationwide survey conducted by the Cardiac Anaesthesia Working Group of the German Society of Anaesthesiology and Intensive Care Medicine].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Vasodilators in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Renal effects of ularitide in patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Diuretics: still the mainstay of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Role of tolvaptan in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Correlation between plasma milrinone concentration and renal function in patients with cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Enhanced external counterpulsation: a new modality in the treatment of angina and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Domestic and foreign trends in the prevalence of heart failure and the necessity of next-generation artificial hearts: a survey by the Working Group on Establishment of Assessment Guidelines for Next-Generation Artificial Heart Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

How many acute heart failure patients need a ventricular assist device?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Guidelines for heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Nonpharmacologic management and health care maintenance in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Dietary guidance in heart failure: a perspective on needs for prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Cardiovascular protection using beta-blockers: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in He

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

A comparison of the aldosterone-blocking agents eplerenone and spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARG

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Use of cardiac resynchronization therapy in patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Advances in the surgical treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Two decades of cardiac transplantation at the Montreal Heart Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Survival analysis in heart transplantation: results from an analysis of 1290 cases in a single center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Device therapy for heart failure: when and for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Mechanical support in acute and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Right-sided heart failure: diagnosis and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Decreased renal function as an independent predictor of re-hospitalization for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

ESPEN Guidelines on Enteral Nutrition: Adult renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of telmisartan on renal outcomes: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Ultrafiltration in diuretic-resistant volume overload in nephrotic syndrome and patients with ascites due to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

A wearable hemofilter for continuous ambulatory ultrafiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Major bleeding in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Ferric carboxymaltose in patients with heart failure and iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Optimized heart failure therapy and complete anemia correction on left-ventricular hypertrophy in nondiabetic and diabetic patients undergoing hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Volume overload in patients treated with continuous ambulatory peritoneal dialysis associated with reduced circadian blood pressure variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The acute cardiac effects of dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Disproportionally low clearance of macromolecules from the plasma to the peritoneal cavity in a mouse model of peritoneal dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: A propensity score and instrumental variable analysis using the Acutely Decompensated H

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

Blood pressure in chronic kidney disease stage 5D—report from a Kidney Disease: Improving Global Outcomes controversies conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ252

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ252

1 reference

22 August 2017

1 reference